Real-World Prevalence of Type 2 Diabetes Remission in a U.S. Insured Population Using a Large Administrative Claims Database

OBJECTIVE: A 2021 international consensus statement defined type 2 diabetes remission as A1C <6.5% measured at least 3 months after cessation of glucose-lowering therapy. We aimed to investigate whether retrospective claims-based data can assess remission based on this definition, whether three i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheils, Natalie E., Jarvis, Megan S., Bangerter, Lauren R., Asch, David A., Clark, Callahan N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425229/
https://www.ncbi.nlm.nih.gov/pubmed/37583561
http://dx.doi.org/10.2337/ds22-0042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425229/
https://www.ncbi.nlm.nih.gov/pubmed/37583561
http://dx.doi.org/10.2337/ds22-0042

Ejemplares similares